Quest Diagnostics Incorporated (DGX)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:46AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 15.38B |
| Enterprise value | 20.26B |
| Trailing P/E | 18.63 |
| Forward P/E | 15.72 |
| PEG ratio (5-yr expected) | 1.62 |
| Price/sales (ttm) | 1.68 |
| Price/book (mrq) | 2.39 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.87 |
| 52-week change 3 | 4.55% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 145.58 |
| 52-week low 3 | 119.59 |
| 50-day moving average 3 | 131.31 |
| 200-day moving average 3 | 130.98 |
Share statistics
| Avg vol (3-month) 3 | 979.1k |
| Avg vol (10-day) 3 | 902.86k |
| Shares outstanding 5 | 111.09M |
| Implied shares outstanding 6 | 112.48M |
| Float 8 | 110.05M |
| % held by insiders 1 | 0.43% |
| % held by institutions 1 | 92.39% |
| Shares short (30 Apr 2024) 4 | 2.8M |
| Short ratio (30 Apr 2024) 4 | 2.44 |
| Short % of float (30 Apr 2024) 4 | 2.88% |
| Short % of shares outstanding (30 Apr 2024) 4 | 2.52% |
| Shares short (prior month 28 Mar 2024) 4 | 2.55M |
Dividends & splits
| Forward annual dividend rate 4 | 3 |
| Forward annual dividend yield 4 | 2.17% |
| Trailing annual dividend rate 3 | 2.88 |
| Trailing annual dividend yield 3 | 2.08% |
| 5-year average dividend yield 4 | 1.91 |
| Payout ratio 4 | 48.32% |
| Dividend date 3 | 22 Apr 2024 |
| Ex-dividend date 4 | 05 Apr 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 21 Jun 2005 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 9.11% |
| Operating margin (ttm) | 13.40% |
Management effectiveness
| Return on assets (ttm) | 6.20% |
| Return on equity (ttm) | 14.15% |
Income statement
| Revenue (ttm) | 9.29B |
| Revenue per share (ttm) | 83.11 |
| Quarterly revenue growth (yoy) | 1.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.78B |
| Net income avi to common (ttm) | 842M |
| Diluted EPS (ttm) | 7.43 |
| Quarterly earnings growth (yoy) | -4.00% |
Balance sheet
| Total cash (mrq) | 474M |
| Total cash per share (mrq) | 4.27 |
| Total debt (mrq) | 5.35B |
| Total debt/equity (mrq) | 81.76% |
| Current ratio (mrq) | 0.97 |
| Book value per share (mrq) | 57.95 |
Cash flow statement
| Operating cash flow (ttm) | 1.33B |
| Levered free cash flow (ttm) | 784M |
© 2024 Yahoo. All rights reserved.